Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Stem Cell Theranostics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013398
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stem Cell Theranostics Inc (Stem Cell Theranostics) is a biotechnology company that develops genetically-targeted therapies for heart failure. The company discovers and develops novel medicines for heart diseases using stem cell-derived, patient-specific cardiac disease models. It also develops a discovery platform that focuses on the generation and use of stem cell-derived, cardiac disease models in drug screening and therapeutic development. The company’s stem cell technology provide development of research and development productivity and controlling clinical development costs. It offers partnerships with healthcare institutes, research center and drug development companies. Stem Cell Theranostics is headquartered in Redwood, California, the US.

Stem Cell Theranostics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Stem Cell Theranostics Enters into Agreement with Capella BioScience 10
Stem Cell Theranostics Enters into Research Agreement with Thermo Fisher Scientific 11
Licensing Agreements 12
iPS Academia Enters into Licensing Agreement with Stem Cell Theranostics 12
Stem Cell Theranostics Enters into Agreement with Stanford University 13
Stem Cell Theranostics Inc – Key Competitors 14
Stem Cell Theranostics Inc – Key Employees 15
Stem Cell Theranostics Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stem Cell Theranostics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Stem Cell Theranostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Stem Cell Theranostics Enters into Agreement with Capella BioScience 10
Stem Cell Theranostics Enters into Research Agreement with Thermo Fisher Scientific 11
iPS Academia Enters into Licensing Agreement with Stem Cell Theranostics 12
Stem Cell Theranostics Enters into Agreement with Stanford University 13
Stem Cell Theranostics Inc, Key Competitors 14
Stem Cell Theranostics Inc, Key Employees 15

★海外企業調査レポート[Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sensimed AG-医療機器分野:企業M&A・提携分析
    Summary Sensimed AG (Sensimed) is a medical device company that offers soft contact lens-based solutions. The company’s products comprise Sensimed Triggerfish, a non-invasive soft contact lens-based solution designed for the overall management of glaucoma. It offers automated recording of continuous …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Biosense Webster Inc:企業の製品パイプライン分析2018
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • The National Bank of Ras Al-Khaimah (P.S.C.):企業の戦略・SWOT・財務分析
    The National Bank of Ras Al-Khaimah (P.S.C.) - Strategy, SWOT and Corporate Finance Report Summary The National Bank of Ras Al-Khaimah (P.S.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Thetis Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Thetis Pharmaceuticals LLC (Thetis Pharma) is a drug manufacturing company that offers novel immuno-resolving therapies. The company develops and manufactures drugs for type two diabetes and chronic conditions. Its pipeline products include TP252, TP6211, TP113, and TP 101. Thetis Pharma’s T …
  • Belize Electricity Ltd:発電所・企業SWOT分析
    Belize Electricity Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Genscript Biotech Corp (1548):製薬・医療:M&Aディール及び事業提携情報
    Summary Genscript Biotech Corp (Genscript Biotech) is a biotechnology company that provides life sciences research and application services and products. The company offers wide range of services in peptide synthesis, gene synthesis, protein expression and engineering, molecular biology, custom anti …
  • SuccessFactors, Inc.:企業の戦略的SWOT分析
    SuccessFactors, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Par Pacific Holdings, Inc. (PARR)-石油・ガス分野:企業M&A・提携分析
    Summary Par Pacific Holdings, Inc. (Par Pacific), formerly known as Par Petroleum Corporation, manages, owns and maintains interests in energy and infrastructure related businesses. It has operations across the value chain from natural gas production to distribution and transportation. The company c …
  • United Microelectronics Corporation (2303):企業の財務・戦略的SWOT分析
    United Microelectronics Corporation (2303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Immatics Biotechnologies GmbH:企業のM&A・事業提携・投資動向
    Immatics Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Immatics Biotechnologies GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Luxfer Holdings PLC (LXFR):企業の財務・戦略的SWOT分析
    Luxfer Holdings PLC (LXFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Harmony Gold Mining Co Ltd:企業の戦略・SWOT・財務情報
    Harmony Gold Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Harmony Gold Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Islamic Insurance Company:企業の戦略・SWOT・財務情報
    The Islamic Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Islamic Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • China Environmental Energy Investment Limited:企業のM&A・事業提携・投資動向
    China Environmental Energy Investment Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Environmental Energy Investment Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Foxconn Technology Co Ltd
    Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BCE Inc (BCE):企業の財務・戦略的SWOT分析
    BCE Inc (BCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Nagacorp Ltd:企業の戦略・SWOT・財務情報
    Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report Summary Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Northern Biologics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Northern Biologics Inc. (Northern Biologics) is a biotech company, which develops a portfolio of antibody therapies for treating cancer. The product pipeline of the company includes MSC-1, a first-in-class antibody that acts against leukemia inhibitory factor (LIF), which is a major immunosu …
  • Acasti Pharma Inc (ACST):製薬・医療:M&Aディール及び事業提携情報
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆